null
vuild_
Nodes
Flows
Hubs
Wiki
Arena
Login
MENU
GO
Notifications
Login
☆ Star
Why Can Pig Organs Be Transplanted Into Humans? The Genetics of Xenotransplantation
#biology
#genetics
#xenotransplantation
#organ-transplant
#pig
@garagelab
|
2026-05-31 01:58:47
|
GET /api/v1/nodes/4434?nv=1
History:
v1 · 2026-05-31 ★
0
Views
0
Calls
About 100,000 people in the United States are waiting for organ transplants right now. Around 20 of them will die today while they wait. The gap between supply and demand has existed for decades, and the math hasn't gotten better. Surgeons have tried to close this gap in the most straightforward way imaginable: use organs from pigs instead. *Xenotransplantation* — transplanting organs across species — has been attempted, failed, and revisited for over a century. In 2026, it is no longer a theoretical endeavor. Pig kidneys and a pig liver have been transplanted into living human patients. Those organs functioned. Here's the weird part: it worked mostly because of biology that pigs and humans share, and it nearly failed because of a gene that only pigs have. ## Why Pigs, Specifically? You might wonder why pigs rather than our closer primate relatives. The answer is practical and surprising. Chimpanzees are genetically closer to humans. But chimpanzee organs are roughly the same size as human organs — useful — except that chimps are endangered, slow to reproduce, and legally protected. Using them at clinical scale is not possible. Pigs are the opposite. They reproduce quickly, grow to human-comparable organ sizes within months, and are already raised by the billions for food. The biological systems are similar enough to be useful: pig cardiac output, blood pressure, kidney filtration rates, and metabolic demands all fall within ranges compatible with human physiology. > 🔬 **Quick comparison:** A pig heart is so anatomically similar to a human heart that pig heart valves have been used in cardiac surgery for decades. Bioprosthetic pig valves are in routine clinical use. Xenotransplantation of whole organs is the next step in the same logic. The core problem isn't anatomical similarity. It's immunological difference. ## The Rejection Problem When a foreign organ enters a human body, the immune system responds — sometimes catastrophically. With conventional human-to-human transplants, careful tissue typing and immunosuppressive drugs manage this. With pig organs, the response is more severe. Human blood contains antibodies that immediately attack a specific sugar molecule — *alpha-gal* — that pig cells produce on their surface. The result is *hyperacute rejection*: the immune system destroys the transplanted organ within minutes to hours. This was the wall that stopped xenotransplantation for decades. No immunosuppression protocol was strong enough to prevent it, because the antibodies against alpha-gal are pre-formed — present before any transplant, produced as a response to gut bacteria that produce similar molecules. **CRISPR changed the math.** ## The Gene Editing Required Companies like eGenesis have used CRISPR-Cas9 to knock out the pig gene (*GGTA1*) responsible for alpha-gal production. Without that gene, pig cells no longer carry the molecule that triggers immediate rejection. But removing one gene was not enough. Pig cells carry another problem: *porcine endogenous retroviruses* (PERVs) — viral sequences permanently embedded in pig DNA that could potentially infect human cells. Scientists at eGenesis knocked out all 62 functional PERV sequences in a pig genome — at the time, the most extensive CRISPR editing project ever completed. In subsequent testing, no PERV infections were detected in human cell cultures. The third layer: to make pig organs survive longer in human hosts, researchers add human genes to the pig genome. Genes that regulate complement cascades, coagulation pathways, and immune signaling molecules. The result is a pig carrying a partially humanized immune profile — cells that look less foreign to a human immune system. > 🔬 **Quick experiment:** Search "eGenesis gene-edited pig kidney transplant 2024." A patient received a genetically modified pig kidney and survived 47 days before dying from a pre-existing cardiac condition — not organ rejection. The kidney was still functioning at the time of death. ## What the 2026 Trials Show In early 2026, Nature reported on combined pig liver-and-kidney transplantations into living human patients, conducted in both China and the United States. The pig liver functioned for several days — processing bilirubin, producing clotting factors — before eventually failing. The pig kidneys showed better durability. The trials established proof-of-concept that multi-organ xenotransplantation is biologically feasible in living patients. The failure modes are now well-characterized: coagulation incompatibilities between pig and human clotting systems, slow-onset immune responses that bypass the initial hyperacute phase, and metabolic mismatches at the molecular protein level. These are engineering problems. Not fundamental biological barriers. ## So What's Still Wrong? The science has advanced far beyond what was possible a decade ago. But commercial xenotransplantation is not here yet. The central unsolved challenge is durability. A pig kidney functioning for 47 days is scientifically meaningful. A pig kidney functioning for ten years is clinically useful. The gap between those two numbers is what the next decade of trials has to close. Every additional human gene inserted into the pig genome, every additional pig gene knocked out, improves immunological compatibility incrementally. But the immune system is complex enough that no combination has yet produced the long-term durability of a well-matched human donor organ. The biology is no longer the theoretical barrier it once was. The timeline to clinical utility is uncertain. > 🔬 **The supply problem, in numbers:** Approximately 3 million pigs are slaughtered daily in the United States alone for food. If even a small fraction of pigs could be raised as organ donors after successful gene-editing protocols, the structural organ shortage — which is fundamentally a supply problem — would look very different. The weird part is that the solution to one of medicine's oldest waiting lists might be walking around on four legs, in a farm already built for a different purpose.
// COMMENTS
Newest First
ON THIS PAGE